MELD SCORE CORRELATION WITH LABORATORY FINDINGS AND COMPLICATIONS OF HEPATITIS C CAUSED LIVER CIRRHOSIS
Abstract
Introduction. Model for End-Stage Liver Disease (MELD) is a scoring system used to estimate the severity of chronic liver disease. Score is based on objective variables and predicts survival among different populations of patients. Study Aim. The aim of the study was to retrospectively analyze potential connection between MELD score and laboratory findings and complications of hepatitis C caused liver cirrhosis. Materials and Methods. A retrospective cross-sectional study based on data from Riga East Clinical University Hospital from the time period of 2010 to 2014 was performed. Original protocol and database were developed with consequential data statistical analysis using IBM SPSS Statistics ver.20.0. Results. In total 221 cirrhosis cases were enrolled in the study. 128 (58%) cases were male and 93 (42%) female. Mean age was 52.7 ± 13.4 years. Statistically significant correlation was found between leukocytes (r = 0.4, p < 0.001), blood urea (r = 0.4, p < 0.001), serum albumin (r = -0.4, p < 0.001), C-reactive protein (r = 0.4, p < 0.001) and MELD score. Higher leukocytes, higher urea, C-reactive protein and lower serum albumin rates give higher MELD score. At the time of hospitalization 208 (94%) of the patients had different complications of liver cirrhosis. Correlation between MELD score varied significantly with esophageal varices (r = 0.2, p < 0.05) and esophageal vein bleeding (r = 0.2, p < 0.05). Results show, if patient is present with esophageal varices and esophageal vein bleeding, MELD score is higher. Conclusion. Patients with higher leukocytes, blood urea nitrogen and lower serum albumin level are presenting higher MELD score. In patients who presented with esophageal varices and esophageal vein bleeding, higher MELD score was observed.
About the Authors
M. .. Mjasnikova
Riga Stradins University
Russian Federation
Russian Federation
I. .. Rudaka
Riga Stradins University
Russian Federation
Russian Federation
I. .. Zeltina
Riga Stradins University; Riga East clinical university hospital
Russian Federation
Russian Federation
S. .. Laivacuma
Riga Stradins University; Riga East clinical university hospital
Russian Federation
Russian Federation
A. .. Derovs
Riga Stradins University; Riga East clinical university hospital
Russian Federation
Russian Federation
References
1. Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease // Clin Mol Hepatol. - 2013. - 19(2), 105-115.
2. Signal AK, Kamath PS. Model for End-stage Liver Disease // J Clin Exp Hepatol. - 2012. - 3(1), 50-60.
3. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease // Hepatology. - 2001. - 33(2), 464-70.
4. Lau T, Ahmad J. Clinical application of the Model for End-Stage Liver Disease (MELD) in hepatic medicine // Hepat Med. - 2013. - 5, 1-10.
5. Cervoni JP, Thevenot T, Weil D et al. C-reactive protein predicts short-term mortality in patients with cirrhosis // J Hepatol. - 2012 - 56(6), 1299-304.
6. Di Martino V, Coutris C, Cervoni JP et al. Prognostic value of C-reactive protein levels in patients with cirrhosis // Liver Transpl. - 2015 - 21(6), 753-60.
7. Pepys MB, Hirschfield GM. C-reactive protein: a critical update // J Clin Invest. - 2003 - 111(12), 1805-812.
8. Myers RP, Shaheen AA, Faris P et al. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list // PLoS One. - 2013 - 8(1), e51926.
9. Myers RP, Tandon P, Ney M et al. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list // Liver Int. - 2014 - 34(8), 1176-83.
10. Hosten AO BUN and Creatinine // Walker HK, Hall WD, Hurst JW (ed.) Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. - Boston: Butterworth, 1990.
11. Decaux G, Dumont I, Naeije N et al. High uric acid and urea clearance in cirrhosis secondary to increased “effective vascular volume” // Am J Med. - 1982 - 73(3), 328-34.
12. Decaux G, Prospert F, Namias B et al. Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion // Gut. - 1992 - 33(8), 1105-108.
13. Bassani L, Fernandes SA, Raimundo FV et al. Lipid Profile of Cirrhotic patients and its association with parognostic scores: a cross-sectional study // Arg Gastroenterol. - 2015 - 52(3), 210-15.
14. Boemeke L, Bassani L, Marroni CA, Gottschall CB Lipid profile in cirrhotic patients and its relation to clinical outcome // Arg Bras Cir Dig. - 2015 - 28(2), 132-35.
15. Abbasi A, Bhutto AR, Butt N et al. Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis? // J Coll Physicians Surg Pak. - 2012 - 22(8), 484-87.
16. Ghadir MR, Riahin AA, Havaspour A et al. The relationship between lipid profile and severity of liver damage in cirrhotic patients // Hepat Mon. - 2010 - 10(4), 285-88.
17. Xiao-Dan Xu, Jian-Jun Dai, Jian-Qing Qian et al. New index to predict esophageal variceal bleeding in cirrhotic patients//World J Gastroenterol. - 2014 - 20(22), 6989-994.
Review
For citations:
Mjasnikova M..., Rudaka I..., Zeltina I..., Laivacuma S..., Derovs A... MELD SCORE CORRELATION WITH LABORATORY FINDINGS AND COMPLICATIONS OF HEPATITIS C CAUSED LIVER CIRRHOSIS. Experimental and Clinical Gastroenterology. 2016;(7):13-17. (In Russ.)
Views:
894
Email this article 